Matches in DBpedia 2014 for { <http://dbpedia.org/resource/MK-2048> ?p ?o. }
Showing items 1 to 36 of
36
with 100 items per page.
- MK-2048 abstract "MK-2048 is a second generation integrase inhibitor, intended to be used against HIV infection. It is superior to the first available integrase inhibitor, raltegravir, in that it inhibits the HIV enzyme integrase 4 times longer. It is being investigated for use as part of pre-exposure prophylaxis (PrEP). It is being developed by Merck & Co.".
- MK-2048 atcPrefix "none".
- MK-2048 iupacName "(6S)-2-(3-chloro-4-fluorobenzyl)-8-ethyl-10-hydroxy-N,6-dimethyl-1,9-dioxo-1,2,6,7,8,9-hexahydropyrazino[1′,2′:1,5]pyrrolo[2,3-d]pyridazine-4-carboxamide".
- MK-2048 pubchem "11554427".
- MK-2048 thumbnail MK-2048.svg?width=300.
- MK-2048 wikiPageID "25019159".
- MK-2048 wikiPageRevisionID "589278964".
- MK-2048 atcPrefix "none".
- MK-2048 c "21".
- MK-2048 chembl "1237018".
- MK-2048 cl "1".
- MK-2048 f "1".
- MK-2048 h "21".
- MK-2048 hasPhotoCollection MK-2048.
- MK-2048 iupacName "-2".
- MK-2048 legalStatus "Investigational".
- MK-2048 molecularWeight "461.87".
- MK-2048 n "5".
- MK-2048 o "4".
- MK-2048 pubchem "11554427".
- MK-2048 smiles "CCN1CCC".
- MK-2048 stdinchi "1".
- MK-2048 stdinchikey "IOYLKNABOQYKKY-JTQLQIEISA-N".
- MK-2048 subject Category:Integrase_inhibitors.
- MK-2048 type Drug.
- MK-2048 type FunctionalSubstance.
- MK-2048 comment "MK-2048 is a second generation integrase inhibitor, intended to be used against HIV infection. It is superior to the first available integrase inhibitor, raltegravir, in that it inhibits the HIV enzyme integrase 4 times longer. It is being investigated for use as part of pre-exposure prophylaxis (PrEP). It is being developed by Merck & Co.".
- MK-2048 label "MK-2048".
- MK-2048 label "MK-2048".
- MK-2048 sameAs MK-2048.
- MK-2048 sameAs m.09gmb7p.
- MK-2048 sameAs Q3273019.
- MK-2048 sameAs Q3273019.
- MK-2048 wasDerivedFrom MK-2048?oldid=589278964.
- MK-2048 depiction MK-2048.svg.
- MK-2048 isPrimaryTopicOf MK-2048.